Home|Journals|Articles by Year|Audio Abstracts RSS - TOC
 

Original Article

AJVS. 2016; 51(1): 78-83


CBPP: Pastoralist Perception Survey on the Problems Associated with T1/44 Vaccine Administration in Abuja, Nigeria

Akinbobola J. Soladoye, Omeje J. Nduka, Akinbobola R. Ifeoluwapo Ayoade, Adamu Andrew, Okaiyeto S. Oluwole.




Abstract

Contagious bovine pleuropneumonia (CBPP) is a disease of cattle that has been difficult to control in Nigeria. This study was done to assess the problem associated with the use of the OIE recommended vaccine against the disease in Nigeria. A total of 180 closed ended questionnaires were administered to pastoralists from the six area councils of Federal Capital Territory, to study the problem associated with T1/44 vaccine administration in Abuja, Nigeria. Data was managed using Microsoft excel and SPSS version 21. The study revealed that out of 172 respondents that were aware that a vaccine exists, 93.9% (95%CI: 90.4-97.4%) do vaccinate their cattle against Contagious Bovine Pleuropneumonia; out of which 46.7% (95%CI: 39.41-53.99%) do an annual vaccination, 4.1% (95%CI: 1.2-7%) vaccinate biennially and 49.1% (95CI: 41.8-56.4%) vaccinate animals once in 5 years. Among the 90 pastoralists that do either a biennial or once in 5 years vaccination, 74.4% (95%CI: 65.38-83.42%) do not follow the recommended vaccination schedule due to post vaccination reactions, which occurred 7- 14 days after vaccination. Majority of these affected respondents manage the reaction by branding with hot objects, while others made use of antibiotics and anti-inflammatory agent.

Key words: CBPP, PASTORALIST PERCEPTION, T1/44, ABUJA






Full-text options


Share this Article



Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Review(er)s Central
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.